Business Description
Aridis Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US0403341045
Description
Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 1.61 | |||||
| 14-Day RSI | 15.53 | |||||
| 6-1 Month Momentum % | -98.57 | |||||
| 12-1 Month Momentum % | -98.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -91.28 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -5.45 | |||||
| EV-to-EBITDA | -8.38 | |||||
| EV-to-Revenue | 0.24 | |||||
| EV-to-Forward-Revenue | 1.05 | |||||
| Earnings Yield (Greenblatt) % | -18.35 | |||||
| FCF Yield % | -448350 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ARDS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aridis Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 19.647 | ||
| EPS (TTM) ($) | -0.162 | ||
| Beta | 1.55 | ||
| Volatility % | 98.74 | ||
| 14-Day RSI | 15.53 | ||
| 14-Day ATR ($) | 0.000219 | ||
| 20-Day SMA ($) | 0.000865 | ||
| 12-1 Month Momentum % | -98.93 | ||
| 52-Week Range ($) | 0.0001 - 0.096 | ||
| Shares Outstanding (Mil) | 44.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aridis Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aridis Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aridis Pharmaceuticals Inc Frequently Asked Questions
What is Aridis Pharmaceuticals Inc(ARDS)'s stock price today?
The current price of ARDS is $0.00. The 52 week high of ARDS is $0.10 and 52 week low is $0.00.
When is next earnings date of Aridis Pharmaceuticals Inc(ARDS)?
The next earnings date of Aridis Pharmaceuticals Inc(ARDS) is 2024-10-21 Est..
Does Aridis Pharmaceuticals Inc(ARDS) pay dividends? If so, how much?
Aridis Pharmaceuticals Inc(ARDS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers